Quality of life measurement in gastrointestinal and liver disorders

被引:145
作者
Borgaonkar, MR [1 ]
Irvine, EJ [1 ]
机构
[1] McMaster Univ, Med Ctr, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada
关键词
D O I
10.1136/gut.47.3.444
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Modern medicine has had a considerable impact on mortality rates for serious illness. Many chronic diseases which have previously been associated with an increased mortality now have survival rates approaching those of the background population. However, chronic diseases such as cancer, chronic pain syndromes, and chronic inflammatory conditions impose a considerable burden on families, the health care system, and society. Health related quality of life (HRQOL) is a concept that has developed from the need to estimate the impact of such chronic diseases. HRQOL measurement is a conceptual framework which attempts to predict daily function and well being based on subjective attitudes and experiences of physical, social, and emotional health. It has been evaluated predominantly from the patient's viewpoint as proxy respondents appear to underestimate the full effect of chronic illness on functional status. Measuring HRQOL in clinical research is most frequently undertaken using multi-item questionnaires to estimate daily function. Factors which affect HRQOL can be broadly classed as disease related and disease independent. The use of different assessment techniques permits comparisons between and within disorders. Generic and disease specific instruments used together enhance the ability to direct treatment for individuals and patient populations. Psychometrically sound questionnaires must be used. However, the type of instrument and research methods adopted depend on the question of interest. We have attempted to catalogue and critically assess the disease specific instruments used in the assessment of chronic gastrointestinal disease.
引用
收藏
页码:444 / 454
页数:11
相关论文
共 139 条
[31]  
Durand-Zaleski I, 1998, CANCER-AM CANCER SOC, V83, P882, DOI 10.1002/(SICI)1097-0142(19980901)83:5<882::AID-CNCR12>3.0.CO
[32]  
2-R
[33]   Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases [J].
Earlam, S ;
Glover, C ;
Fordy, C ;
Burke, D ;
AllenMersh, TG .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :171-175
[34]  
EVERHART JE, 1994, PUB US DEP HLTH HUMA
[35]   GASTROINTESTINAL QUALITY-OF-LIFE INDEX - DEVELOPMENT, VALIDATION AND APPLICATION OF A NEW INSTRUMENT [J].
EYPASCH, E ;
WILLIAMS, JI ;
WOODDAUPHINEE, S ;
URE, BM ;
SCHMULLING, C ;
NEUGEBAUER, E ;
TROIDL, H .
BRITISH JOURNAL OF SURGERY, 1995, 82 (02) :216-222
[36]   QUALITY-OF-LIFE ASSESSMENT BY PATIENTS WITH INFLAMMATORY BOWEL-DISEASE [J].
FARMER, RG ;
EASLEY, KA ;
FARMER, JM .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 1992, 59 (01) :35-42
[37]   Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis [J].
Farup, CE ;
Leidy, NK ;
Murray, M ;
Williams, GR ;
Helbers, L ;
Quigley, EMM .
DIABETES CARE, 1998, 21 (10) :1699-1706
[38]   Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia [J].
Fass, R ;
Fullerton, S ;
Naliboff, B ;
Hirsh, T ;
Mayer, EA .
DIGESTION, 1998, 59 (01) :79-85
[39]   Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients [J].
Fattovich, G ;
Giustina, G ;
Degos, F ;
Tremolada, F ;
Diodati, G ;
Almasio, P ;
Nevens, F ;
Solinas, A ;
Mura, D ;
Brouwer, JT ;
Thomas, H ;
Njapoum, C ;
Casarin, C ;
Bonetti, P ;
Fuschi, P ;
Basho, J ;
Tocco, A ;
Bhalla, A ;
Galassini, R ;
Noventa, F ;
Schalm, SW ;
Realdi, G .
GASTROENTEROLOGY, 1997, 112 (02) :463-472
[40]   METHOTREXATE FOR THE TREATMENT OF CROHNS-DISEASE [J].
FEAGAN, BG ;
ROCHON, J ;
FEDORAK, RN ;
IRVINE, EJ ;
WILD, G ;
SUTHERLAND, L ;
STEINHART, AH ;
GREENBERG, GR ;
GILLIES, R ;
HOPKINS, M ;
HANAUER, SB ;
MCDONALD, JWD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (05) :292-297